| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |